ADRs Advance; Connect Biopharma Holdings Climbs 19%
This article was automatically generated by MarketWatch using technology from Automated Insights.
International stocks trading in New York closed higher on Friday, as the S&P/BNY Mellon index of American depositary receipts rose 0.1% to 183.93.
The European index dropped 0.3% to 178.52. The Asian index added 0.7% to 219.12. The Latin American index declined 0.4% to 189.48, while the emerging-markets index added 0.3% to 353.54.
China's Connect Biopharma Holdings was the biggest leader during the session, jumped 19% to $1.52, and China-based Concord Medical Services Holdings surged 15% to 95 cents. Fangdd Network Group, which is based in China, rounded out the top three leaders on Friday, with shares that increased 8.9% to 59 cents.
NaaS Technology, based in China, posted the largest decline, tumbled 16% to $2.43, followed by shares of China's Adlai Nortye, which declined 12% to $3.26. Shares of United Kingdom-based Renalytix lost 11% to 23 cents.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 28, 2024 17:05 ET (21:05 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: US Jobs Report in View as Q3 Begins
-
Q3 2024 Stock Market Outlook: Is the AI Stock Trade Over?
-
Ian Bremmer: 4 Big Geopolitical Risks to Watch
-
What’s Happening In the Markets This Week
-
Obesity Drug Stocks: Why It Will Be ‘Exceptionally Difficult’ to Dethrone Eli Lilly and Novo Nordisk
-
What Does Chipotle’s Stock Split Mean for Investors?
-
5 Stocks to Buy Before the Fed Cuts Interest Rates in 2024
-
Markets Brief: Inflation Is Back In the Spotlight
-
10 Top Dividend Stocks for 2024
-
Finding Small-Cap Stock Opportunities In a Big-Cap World
-
The 10 Best Companies to Invest in Now
-
Nike Earnings: Dim Sales Outlook Slams Shares, but Patient Investors Could Be Rewarded
-
2 Top E-Commerce Stock Picks
-
Our Top Pick for Investing in US Renewable Energy
-
Micron Earnings: We Raise Our DRAM Forecast and Valuation Behind Stronger Pricing Assumptions
-
10 Undervalued Wide-Moat Stocks